Canine mast cell tumors are a heterogenous disease with a range of presentations and outcomes. As a result, a range of treatment modalities are used. This lecture will provide an in-depth exploration of various treatment modalities for canine mast cell tumors, with a focus on options that are readily accessible in primary care practice. Attendees will gain a comprehensive understanding of how these treatments work, their benefits, potential side effects, and factors that influence treatment decisions.

This session originally was presented at AVMA Convention 2024.

1.0 CE Credit
$15 AVMA/SAVMA Members
$30 Non-members